CN103656763A - 一种纳米多涂层药物支架及制备方法 - Google Patents
一种纳米多涂层药物支架及制备方法 Download PDFInfo
- Publication number
- CN103656763A CN103656763A CN201310672334.9A CN201310672334A CN103656763A CN 103656763 A CN103656763 A CN 103656763A CN 201310672334 A CN201310672334 A CN 201310672334A CN 103656763 A CN103656763 A CN 103656763A
- Authority
- CN
- China
- Prior art keywords
- coating
- plga
- redv
- stent
- tio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011248 coating agent Substances 0.000 title claims abstract description 50
- 238000000576 coating method Methods 0.000 title claims abstract description 50
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229910052751 metal Inorganic materials 0.000 claims abstract description 19
- 229910001220 stainless steel Inorganic materials 0.000 claims abstract description 19
- 239000010935 stainless steel Substances 0.000 claims abstract description 19
- 239000002184 metal Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 17
- 229920001690 polydopamine Polymers 0.000 claims abstract description 17
- 229960002930 sirolimus Drugs 0.000 claims abstract description 17
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims abstract description 13
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims description 24
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 18
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 15
- 239000002356 single layer Substances 0.000 claims description 15
- 239000000919 ceramic Substances 0.000 claims description 10
- 229960003638 dopamine Drugs 0.000 claims description 9
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 9
- 239000012498 ultrapure water Substances 0.000 claims description 9
- 239000010410 layer Substances 0.000 claims description 8
- 239000000178 monomer Substances 0.000 claims description 8
- 238000010276 construction Methods 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000011247 coating layer Substances 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 238000007590 electrostatic spraying Methods 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 238000005530 etching Methods 0.000 claims description 3
- 238000004880 explosion Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000001755 magnetron sputter deposition Methods 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 239000003595 mist Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 238000010926 purge Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000000523 sample Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract description 8
- 208000037803 restenosis Diseases 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 4
- 208000032843 Hemorrhage Diseases 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000005524 ceramic coating Methods 0.000 abstract 2
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 108010024668 arginyl-glutamyl-aspartyl-valine Proteins 0.000 abstract 1
- 210000003989 endothelium vascular Anatomy 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 description 13
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 229960004275 glycolic acid Drugs 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000001435 Thromboembolism Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 210000003090 iliac artery Anatomy 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000005274 electrospray deposition Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000016768 molybdenum Nutrition 0.000 description 1
- 239000002103 nanocoating Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000002094 self assembled monolayer Substances 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310672334.9A CN103656763B (zh) | 2013-12-10 | 2013-12-10 | 一种纳米多涂层药物支架及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310672334.9A CN103656763B (zh) | 2013-12-10 | 2013-12-10 | 一种纳米多涂层药物支架及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103656763A true CN103656763A (zh) | 2014-03-26 |
CN103656763B CN103656763B (zh) | 2015-02-04 |
Family
ID=50296315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310672334.9A Expired - Fee Related CN103656763B (zh) | 2013-12-10 | 2013-12-10 | 一种纳米多涂层药物支架及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103656763B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105816921A (zh) * | 2016-04-20 | 2016-08-03 | 山东百多安医用材料改性工程技术中心 | 一种仿生血管支架及其制备方法 |
CN106835130A (zh) * | 2017-01-24 | 2017-06-13 | 山东科技大学 | 一种以镁/镁合金为基体的多涂层复合材料及其制备方法 |
CN110441193A (zh) * | 2019-07-31 | 2019-11-12 | 山东吉威医疗制品有限公司 | 一种无聚合物药物涂层洗脱支架载药密度的测定方法 |
CN111035485A (zh) * | 2019-12-16 | 2020-04-21 | 西南交通大学 | 一种血管支架及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020188037A1 (en) * | 1999-04-15 | 2002-12-12 | Chudzik Stephen J. | Method and system for providing bioactive agent release coating |
CN1708603A (zh) * | 2002-10-31 | 2005-12-14 | 塞比奥科技公司 | 制备结构化陶瓷涂层的方法和由此制备的具有涂层的器件 |
CN102210890A (zh) * | 2011-05-26 | 2011-10-12 | 浙江大学 | 用于心血管支架的内皮细胞选择性复合涂层材料及其制备方法 |
EP2532373A1 (en) * | 2010-02-03 | 2012-12-12 | National Institute for Materials Science | Biocompatible device |
CN203634536U (zh) * | 2013-12-10 | 2014-06-11 | 中国医科大学附属第四医院 | 一种纳米多涂层药物支架 |
-
2013
- 2013-12-10 CN CN201310672334.9A patent/CN103656763B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020188037A1 (en) * | 1999-04-15 | 2002-12-12 | Chudzik Stephen J. | Method and system for providing bioactive agent release coating |
CN1708603A (zh) * | 2002-10-31 | 2005-12-14 | 塞比奥科技公司 | 制备结构化陶瓷涂层的方法和由此制备的具有涂层的器件 |
EP2532373A1 (en) * | 2010-02-03 | 2012-12-12 | National Institute for Materials Science | Biocompatible device |
CN102210890A (zh) * | 2011-05-26 | 2011-10-12 | 浙江大学 | 用于心血管支架的内皮细胞选择性复合涂层材料及其制备方法 |
CN203634536U (zh) * | 2013-12-10 | 2014-06-11 | 中国医科大学附属第四医院 | 一种纳米多涂层药物支架 |
Non-Patent Citations (2)
Title |
---|
C.J.PAN等: "Preparation and characterization of rapamyccin-loaded PLGA coating stent", 《J MATER SCI:MATER MED》 * |
魏雨等: "REDV/雷帕霉素复合涂层构建内皮细胞选择性功能界面", 《高等学校化学学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105816921A (zh) * | 2016-04-20 | 2016-08-03 | 山东百多安医用材料改性工程技术中心 | 一种仿生血管支架及其制备方法 |
CN106835130A (zh) * | 2017-01-24 | 2017-06-13 | 山东科技大学 | 一种以镁/镁合金为基体的多涂层复合材料及其制备方法 |
CN106835130B (zh) * | 2017-01-24 | 2018-11-20 | 山东科技大学 | 一种以镁/镁合金为基体的多涂层复合材料及其制备方法 |
CN110441193A (zh) * | 2019-07-31 | 2019-11-12 | 山东吉威医疗制品有限公司 | 一种无聚合物药物涂层洗脱支架载药密度的测定方法 |
CN111035485A (zh) * | 2019-12-16 | 2020-04-21 | 西南交通大学 | 一种血管支架及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103656763B (zh) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9040111B2 (en) | Method of making a stent | |
Nazneen et al. | Surface chemical and physical modification in stent technology for the treatment of coronary artery disease | |
Capuani et al. | Advanced strategies to thwart foreign body response to implantable devices | |
CN103656763B (zh) | 一种纳米多涂层药物支架及制备方法 | |
CN104189963A (zh) | 降低可全降解镁合金血管支架降解速率的表面涂层制备方法 | |
Rao et al. | Nitric oxide-producing cardiovascular stent coatings for prevention of thrombosis and restenosis | |
Jeong et al. | Augmented re-endothelialization and anti-inflammation of coronary drug-eluting stent by abluminal coating with magnesium hydroxide | |
AU2007204550A1 (en) | Pharmaceutical compounds that contain nanoparticles useful for treating restenotic lesions | |
EP2380528A1 (en) | Medicament eluting apparatus with micro-hole structure capable of storing and releasing multiple medicines and preparation method | |
JP2004173770A (ja) | 体内埋込医療器具 | |
JP2014531933A (ja) | 介入医療機器およびその製造方法 | |
JP2014530058A (ja) | 介入医療機器およびその製造方法 | |
Son et al. | Multilayered electrospun fibrous meshes for restenosis‐suppressing metallic stents | |
US20130004548A1 (en) | Medical devices having pharmacological active agent releasing material | |
Ebrahimi-Nozari et al. | Multimodal effects of asymmetric coating of coronary stents by electrospinning and electrophoretic deposition | |
CN203634536U (zh) | 一种纳米多涂层药物支架 | |
JP2015154925A (ja) | 耐食性に優れたステント | |
US8591571B2 (en) | Drug-eluting stent | |
US20070118211A1 (en) | Method for preparing drug eluting medical devices and devices obtained therefrom | |
CN105709279B (zh) | Plga-s1p纳米材料及plga-s1p纳米涂层支架的制备方法 | |
CN101641059A (zh) | 一种不对称药物控释涂层冠脉内支架 | |
Vallejo-Zamora et al. | Drug-Eluting, Bioresorbable Cardiovascular Stents─ Challenges and Perspectives | |
CN107137790B (zh) | 一种表面附着药物涂层的全降解聚合物支架及其制备方法 | |
JP2016163619A (ja) | 防食効果を利用したマグネシウムの分解速度制御 | |
Wang et al. | In vitro pharmacokinetics of sirolimus-coated stent for tracheal stenosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: XU XIANGSHAN Effective date: 20140514 Owner name: THE FOURTH AFFILIATED HOSPITAL OF CHINA MEDICAL UN Free format text: FORMER OWNER: JIN YUANZHE Effective date: 20140514 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140514 Address after: Huanggu District of Shenyang City, 110032 East Road, located in Liaoning province No. 4 Applicant after: Attached the 4th hospital of Chinese Medical Sciences University Address before: Huanggu District of Shenyang City, 110032 East Road, located in Liaoning province No. 4 Applicant before: Jin Yuanzhe Applicant before: Xu Xiangshan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150204 Termination date: 20191210 |